Professional Seasonal Analysis for Trading

Sonoma Pharmaceuticals, Inc. - Common Stock (SNOA)

Seasonality Analysis

Stocks 20 Years Analyzed

Sonoma Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

-13.86%
Avg Annual Return
38.2%
Avg Monthly Win Rate
5/12
Positive Months
20
Years Analyzed

Sonoma Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 1.38%
60%
Moderate
February -1.66%
50%
Weak
March -2.63%
35%
Very Weak
April 0.70%
35%
Weak
May BEST 18.64%
53%
Moderate
June -4.50%
32%
Very Weak
July 1.88%
32%
Weak
August -7.28%
21%
Very Weak
September -5.35%
42%
Weak
October -10.53%
32%
Very Weak
November WORST -15.12%
16%
Very Weak
December 10.60%
53%
Moderate

Sonoma Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
9.83
Historical Avg Position
46.65
Deviation
-36.82
Performance
Significantly Below Average

Sonoma Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for SNOA with overlay patterns, custom date ranges, and more.

Create Free Account

Sonoma Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Sonoma Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for SNOA across multiple timeframes.

Create Free Account

About Sonoma Pharmaceuticals, Inc. - Common Stock (SNOA) Seasonality

Sonoma Pharmaceuticals, Inc. - Common Stock (SNOA) has been analyzed using 20 years of historical data to identify seasonal patterns. Classified under Stocks, Sonoma Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Sonoma Pharmaceuticals, Inc. - Common Stock is historically May, with an average return of 18.64% and a win rate of 53%. Conversely, November tends to be the weakest month, averaging -15.12% return.

Looking at the full calendar year, Sonoma Pharmaceuticals, Inc. - Common Stock has an average annual return of -13.86% with an overall monthly win rate of 38.2%. Out of 12 months, 5 typically show positive average returns.

The seasonal pattern for Sonoma Pharmaceuticals, Inc. - Common Stock has a consistency score of 55.4 (Fair), based on 20 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Sonoma Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Sonoma Pharmaceuticals, Inc. - Common Stock (SNOA)?

Historically, May has been the best month for Sonoma Pharmaceuticals, Inc. - Common Stock, with an average return of 18.64% and a win rate of 53%. However, past performance does not guarantee future results.

What is the worst month for Sonoma Pharmaceuticals, Inc. - Common Stock (SNOA)?

Based on historical data, November has been the weakest month for Sonoma Pharmaceuticals, Inc. - Common Stock, with an average return of -15.12%. This is a historical observation and does not guarantee future results.

How reliable is SNOA seasonality data?

The seasonality analysis for Sonoma Pharmaceuticals, Inc. - Common Stock is based on 20 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Sonoma Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Sonoma Pharmaceuticals, Inc. - Common Stock (SNOA) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.